ClassID:

20519

A61K31/7034 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin

Sub-classes:
Recent Application in this class:
#1
20260139221
2026-05-21

Akkermansia muciniphila MG784 for alleviating constipation,promoting defecation, improving intestinal barrier function and intestinal immunity, and its uses

#2
20260137644
2026-05-21

COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER

#3
20260132163
2026-05-14

BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA

#4
20260130854
2026-05-14

PREPARATION OF NANO LINIMENT FOR EXTERNAL TREATMENT OF GOUT

#5
20260130853
2026-05-14

METHOD OF TREATING GOUT BY TOPICAL APPLICATION OF NANO LINIMENT

#6
20260130852
2026-05-14

BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY

#7
20260124163
2026-05-07

SOFT GUMMY

#8
20260097058
2026-04-09

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#9
20260097057
2026-04-09

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS

#10
20260076987
2026-03-19

INJECTABLE HYDROGEL FOR PET ENDOMETRITIS, AND PREPARATION METHOD AND USE THEREOF

#11
20260053836
2026-02-26

CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF

#12
20260053773
2026-02-26

PHARMACEUTICAL COMPOSITION AND USE THEREOF

#13
20260041725
2026-02-12

MYCONOSIDE-RICH EXTRACT FROM IN VITRO SYSTEMS OF PLANTS BELONGING TO GENERA HABERLEA AND RAMONDA, METHOD OF PREPARATION, AND USE AS CHEMO-, RADIO- AND UV PROTECTOR

#14
20260034155
2026-02-05

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#15
20260027163
2026-01-29

GUT MICROBIOME BACTERIA AND ENZYMES THAT METABOLIZE DIETARY AND MEDICINAL PLANT SMALL MOLECULES TO AFFECT GUT MICROBIOME

#16
20260027112
2026-01-29

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#17
20260027110
2026-01-29

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

#18
20260021155
2026-01-22

Composition for enhancing exercise performance, increasing muscle mass, improving muscle functions, or preventing or treating muscular disease containing Polygonum multiflorum Thunberg extract

#19
20250381206
2025-12-18

INVARIANT NATURAL KILLER T-CELL ACTIVATORS

#20
20250367226
2025-12-04

ANTI-MALASSEZIA AGENT

#21
20250367153
2025-12-04

COMPOSITION AND APPLICATION THEREOF

#22
20250352606
2025-11-20

Pharmaceutical Composition for Promoting Neurogenesis and Method of Utilizing Gastrodia Elata Extract or Adenosine Analog for Promoting Neurogenesis

#23
20250352502
2025-11-20

TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE

#24
20250345352
2025-11-13

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#25
20250332183
2025-10-30

COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH

#26
20250312405
2025-10-09

FOOD SUPPLEMENT COMPRISING NEOHESPERIDIN DIHYROCHALCONE AND PEPPERMINT OIL

#27
20250304609
2025-10-02

POLYMORPHIC FORM OF CHALCONE GLYCOSIDE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF

#28
20250281428
2025-09-11

Method Of Treating Major Depressive Disorder

#29
20250268971
2025-08-28

SAFFRON AS ANTI-INFLAMMATORY AGENT IN TREATING INFLAMMATORY BOWEL DISEASE

#30
20250268929
2025-08-28

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#31
20250262229
2025-08-21

APPLICATION OF PHD2 INHIBITOR IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF PLATELET THROMBUS

#32
20250255927
2025-08-14

COMPOSITIONS AND METHODS FOR ALLEVIATING ADVERSE EFFECTS FROM RESPONSIBLE ALCOHOL CONSUMPTION

#33
20250241996
2025-07-31

COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES

#34
20250236578
2025-07-24

NOVEL CANNABINOID DERIVATIVES

#35
20250205317
2025-06-26

METHODS AND COMPOSITIONS FOR THE TREATMENT OF STROKE

#36
20250195454
2025-06-19

METHOD OF TREATING MAJOR DEPRESSIVE DISORDER

#37
20250177467
2025-06-05

COMPOSITIONS AND METHODS FOR MODULATING NUCLEAR FACTOR OF ACTIVATED T-CELLS (NFAT) ACTIVITY OF T CELLS

#38
20250177426
2025-06-05

METHODS AND COMPOSITIONS FOR TREATING DEMENTIA

#39
20250161338
2025-05-22

Compounds for Anti-aging Intervention

#40
20250152614
2025-05-15

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

#41
20250120991
2025-04-17

TOPICAL ANALGESIC

#42
20250108086
2025-04-03

LICORICE EXTRACT

#43
20250090598
2025-03-20

SYSTEMS AND METHODS FOR THROMBOSIS PREVENTION

#44
20250090565
2025-03-20

Compositions and Methods for Treating Bleeding and Bleeding Disorders

#45
20250082713
2025-03-13

Active ingredient groups and their key target combinations for the treatment of UC

#46
20250082705
2025-03-13

COMPOSITION FOR IMPROVING, PREVENTING, OR TREATING SLEEP DISORDERS COMPRISING DENDROPANAX MORBIFERA EXTRACTS

#47
20250082641
2025-03-13

A PHARMACEUTICAL COMPOSITION COMPRISING COMBINATION OF SGLT2 INHIBITOR AND DPP-IV INHIBITOR

#48
20250049874
2025-02-13

RHODIOLA ROSEA NANOEMULSION AND PREPARATION METHOD THEREOF

#49
20250043285
2025-02-06

Mammalian ATG8 Proteins and ATG9A Direct Sealing of Autophagosomal Membranes

#50
20250041374
2025-02-06

WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS

#51
20250000849
2025-01-02

COMPOSITE COMPOSITION CONTAINING ANGIOTENSIN RECEPTOR BLOCKER AND SGLT2 INHIBITOR

#52
20240409572
2024-12-12

COMPOUND FOR TREATING NEURODEGENERATIVE DISEASES AND ITS ISOLATION METHOD THEREOF

#53
20240408114
2024-12-12

METHODS FOR PREVENTING AND TREATING ACUTE KIDNEY INJURY

#54
20240398845
2024-12-05

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES

#55
20240398719
2024-12-05

CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS

#56
20240382423
2024-11-21

EXTERNAL NANO LINIMENT FOR GOUT AND PREPARATION METHOD THEREOF

#57
20240374618
2024-11-14

COMPOSITION OF TANNIC ACID AND VITAMIN D AND METHODS OF USE

#58
20240358789
2024-10-31

Compositions and methods for alleviating adverse effects from responsible alcohol consumption

#59
20240358731
2024-10-31

SUMO PATHWAY AS AN OXYGEN SENSOR RELEVANT TO THE PATHOPHYSIOLOGY OF PULMONARY ARTERY HYPERTENSION AND CARDIAC ARRHYTHMIA

#60
20240358698
2024-10-31

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

#61
20240342203
2024-10-17

COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER

#62
20240325356
2024-10-03

Prophylactic and therapeutic drug for nonalcoholic fatty liver disease

#63
20240316087
2024-09-26

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

#64
20240307426
2024-09-19

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS

#65
20240299357
2024-09-12

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION COMPRISING GLUCOKINASE ACTIVATOR AND DPP-IV INHIBITOR, AND PREPARATION METHOD AND USE THEREOF

#66
20240293347
2024-09-05

COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION

#67
20240285605
2024-08-29

DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE

#68
20240277742
2024-08-22

TRANSLATION INHIBITOR WITHOUT OCCUPYING RIBOSOME RESOURCES AS ANTI-TUMOR DRUG

#69
20240277729
2024-08-22

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

#70
20240238322
2024-07-18

THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME

#71
20240226125
2024-07-11

USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

#72
20240225995
2024-07-11

CREAM FOR TREATING ACNE AND MELASMA

#73
20240216462
2024-07-04

PHARMACEUTICAL COMPOSITION FOR ENHANCING IMMUNITY OR ANTI-CANCER ACTIVITY INCLUDING EXTRACT OF PSEUDOLYSIMACHION NAKAIANUM (OHWI) T.YAMAZ AS ACTIVE INGREDIENT

#74
20240216408
2024-07-04

ANTIOXIDANT COMPOSITION COMPRISING POLYDATIN AND ACETYLCYSTEINE

#75
20240207233
2024-06-27

MEDICAMENT

#76
20240207179
2024-06-27

WATER-SOLUBLE CANNABINOID FOOD AND BEVERAGE ADDITIVE HAVING ENHANCED STABILITY

#77
20240197928
2024-06-20

SODIUM-DEPENDENT GLUCOSE TRANSPORTER 2 AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR PRE-MALIGNANT LESIONS

#78
20240189383
2024-06-13

Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis

#79
20240189257
2024-06-13

COMPOSITIONS AND METHODS FOR MANAGING NEPHROPATHY

#80
20240180989
2024-06-06

LIGUSTRUM LUCIDUM EXTRACT USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN

#81
20240180945
2024-06-06

COMPOUNDS AND PHARMACEUTICAL USES THEREOF

#82
20240156848
2024-05-16

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#83
20240148764
2024-05-09

INHIBITORS OF SGLT-1 AND USES THEREOF

#84
20240148673
2024-05-09

ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS

#85
20240130959
2024-04-25

CREAM FOR TREATING ACNE AND MELASMA

#86
20240122954
2024-04-18

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NEUROINFLAMMATION, COMPRISING ELEUTHEROSIDE B AS ACTIVE INGREDIENT

#87
20240116970
2024-04-11

HIGH-PURITY STEVIOL GLYCOSIDES

#88
20240099960
2024-03-28

DENDROBIUM FIMBRIATUM EXTRACT AND NO-RINSE COSMETIC COMPOSITION COMPRISING SAME

#89
20240091174
2024-03-21

Method Of Treating Major Depressive Disorder

#90
20240074992
2024-03-07

Method Of Treating Major Depressive Disorder

#91
20240074991
2024-03-07

Method of treating major depressive disorder

#92
20240066046
2024-02-29

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#93
20240066045
2024-02-29

SEMICARBAZONE-BASED SAPONIN CONJUGATE

#94
20240058331
2024-02-22

COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION

#95
20240050458
2024-02-15

Compositions And Methods For Inducing Apopotosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

#96
20240050456
2024-02-15

USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES

#97
20240024399
2024-01-25

BIOACTIVE COMPOUNDS EXTRACTION FROM PLANT MATTERS OF SILYBUM MARIANUM AND USAGE

#98
20240009195
2024-01-11

NOVEL USES

#99
20230414642
2023-12-28

METHODS OF MOBILIZING MARROW INFILTRATING LYMPHOCYTES AND USES THEREOF

#100
20230398137
2023-12-14

METHODS FOR LOWERING HBA1C LEVEL WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR

#101
20230390221
2023-12-07

PHARMACEUTICAL COMPOSITIONS WITH LOW AMOUNTS OF NITROSAMINE IMPURITIES AND METHODS FOR PRODUCING THE SAME

#102
20230381101
2023-11-30

AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS

#103
20230374052
2023-11-23

Methods of preparing steviol glycosides and uses of the same

#104
20230372374
2023-11-23

VETERINARY PHARMACEUTICAL FORMULATIONS

#105
20230372290
2023-11-23

FORMULATIONS COMPRISING BOTANICAL EXTRACTS

#106
20230365609
2023-11-16

HIGHLY POTENT MULTIMERIC E-SELECTIN ANTAGONISTS

#107
20230364119
2023-11-16

AUTOPHAGY ACTIVATOR

#108
20230364077
2023-11-16

Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases

#109
20230355646
2023-11-09

AUTOPHAGY ACTIVATOR

#110
20230346952
2023-11-02

CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS

#111
20230346817
2023-11-02

COMPOSITION AND USE OF SGLT-2 INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKERS

#112
20230346748
2023-11-02

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF

#113
20230338406
2023-10-26

USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS

#114
20230338334
2023-10-26

A PHARMACEUTICAL FORMULATION TO TREAT ACUTE AND CHRONIC PANCREATITIS

#115
20230330120
2023-10-19

COMPOSITION FOR PREVENTING HAIR LOSS OR PROMOTING HAIR REGROWTH

#116
20230321140
2023-10-12

MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF

#117
20230310475
2023-10-05

METHODS FOR TREATMENT OF POST-SURGERY LAXITY OF TENDONS AND TENDON REPAIR

#118
20230310414
2023-10-05

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS WITH DOUBLE AND TRIPLE COMBINATIONS OF ANTIVIRAL AND IMMUNE MODULATING COMPOUNDS

#119
20230302030
2023-09-28

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPase

#120
20230285349
2023-09-14

PHARMACEUTICAL COMPOSITION COMPRISING PALMITOYLETHANOLAMIDE AND L-ACETYLCARNITINE

#121
20230277471
2023-09-07

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

#122
20230270805
2023-08-31

A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF

#123
20230263813
2023-08-24

Method for prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin

#124
20230255890
2023-08-17

COMPOSITE FORMULATION COMPRISING SITAGLIPTIN AND DAPAGLIFLOZIN AND PREPARATION METHOD THEREFOR

#125
20230241085
2023-08-03

CANNABINOID AND SUGAR ALCOHOL COMPLEX, METHODS TO MAKE AND USE

#126
20230233495
2023-07-27

Topical formulations of cyclooxygenase inhibitors and their use

#127
20230233487
2023-07-27

Method of treating major depressive disorder

#128
20230218649
2023-07-13

COMPOSITIONS AND METHODS FOR OVERCOMING MICROENVIRONMENT-MEDIATED RESISTANCE VIA E-SELECTIN TARGETING

#129
20230201295
2023-06-29

Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

#130
20230201174
2023-06-29

COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES

#131
20230190852
2023-06-22

COMPOSITIONS AND METHODS FOR JOINT HEALTH

#132
20230190704
2023-06-22

DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES THEREOF

#133
20230183323
2023-06-15

METHODS FOR PREVENTING, REVERSING OR TREATING A COVID-19 INFECTION

#134
20230181610
2023-06-15

Methods and Compositions for Treatment of Cystic Fibrosis Class I Mutations

#135
20230173082
2023-06-08

ANTIBACTERIAL PRODUCTS

#136
20230165882
2023-06-01

COMPOUNDS AND METHODS FOR REDUCTION OF CANCER CELL BURDEN AND PROTECTION OF NORMAL HEMATOPOIESIS

#137
20230149334
2023-05-18

CALORIC RESTRICTION MIMETIC COMPOSITIONS

#138
20230149314
2023-05-18

ORAL COMPLEX TABLET COMPRISING SITAGLIPTIN, DAPAGLIFLOZIN, AND METFORMIN

#139
20230140631
2023-05-04

TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS

#140
20230133762
2023-05-04

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

#141
20230127765
2023-04-27

COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4

#142
20230119894
2023-04-20

THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE

#143
20230115867
2023-04-13

Pemafibrate dosing regimens

#144
20230101466
2023-03-30

Method for producing a polyphenolic composition from barley malt

#145
20230097694
2023-03-30

E-selectin antagonist compounds, compositions, and methods of use

#146
20230059958
2023-02-23

ANTIMICROBIAL BLADDER ADDITIVES SYSTEM AND METHOD

#147
20230059230
2023-02-23

CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF

#148
20230044738
2023-02-09

DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS

#149
20230033327
2023-02-02

COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#150
20230012936
2023-01-19

COMBINATION THERAPY USING GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY

#151
20230000887
2023-01-05

Novel Immunodulating Small Molecules

#152
20220409570
2022-12-29

COMPOSITION OF N-PALMITOYL-ETHANOLAMIDE AND BAICALEIN IN CO-MICRONIZED FORM

#153
20220402960
2022-12-22

BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF PSEUDOMONAS AERUGINOSA

#154
20220387365
2022-12-08

TUCARESOL DERIVATIVES AND USES THEREOF

#155
20220378812
2022-12-01

Topical analgesic

#156
20220378737
2022-12-01

TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS

#157
20220378729
2022-12-01

TOPICAL FORMULATIONS OF CYCLOOXYGENASE INHIBITORS AND THEIR USE

#158
20220370485
2022-11-24

COMPOUNDS AND METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISEASES AND CONDITIONS

#159
20220362260
2022-11-17

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET

#160
20220354877
2022-11-10

Application of tannic acid in preparation of medicament against respiratory viruses

#161
20220339274
2022-10-27

BIOMATERIAL-BASED ANTIGEN FREE VACCINE AND THE USE THEREOF

#162
20220331372
2022-10-20

Systems and methods for thrombosis prevention

#163
20220331348
2022-10-20

METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION

#164
20220323531
2022-10-13

Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions

#165
20220323470
2022-10-13

Composition and use thereof in the manufacture of medicament for treating cancer

#166
20220313716
2022-10-06

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#167
20220305042
2022-09-29

Drug Delivery Composition Comprising a Self-Assembled Gelator

#168
20220296588
2022-09-22

Pemafibrate dosing regimens

#169
20220290200
2022-09-15

GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS

#170
20220288097
2022-09-15

Method of treating oxidative stress due to radiation exposure

#171
20220265691
2022-08-25

METHODS FOR USE OF GENE EXPRESSION AS AN INDICATOR OF E-SELECTIN INHIBITOR EFFICACY AND CLINICAL OUTCOME FOR MULTIPLE TUMOR TYPES

#172
20220257627
2022-08-18

Pemafibrate dosing regimens

#173
20220249617
2022-08-11

CYCLODEXTRIN BASED INJECTABLE COFORMULATIONS OF SGLT2 INHIBITORS AND INCRETIN PEPTIDES

#174
20220241306
2022-08-04

CHITIN ANALOGS FOR THE TREATMENT OF KIDNEY DISEASES

#175
20220226358
2022-07-21

MIXTURE OF INOSITOL DERIVATIVES

#176
20220226294
2022-07-21

Method of treating focal segmental glomerulosclerosis

#177
20220218730
2022-07-14

Compounds and pharmaceutical uses thereof

#178
20220193396
2022-06-23

IONTOPHORESIS ADMINISTRATION DEVICE

#179
20220193102
2022-06-23

COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)

#180
20220175799
2022-06-09

COMPOSITIONS HAVING THE ABILITY TO PROMOTE HEALTHY CHOLESTEROL LEVELS

#181
20220168428
2022-06-02

CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF SYNTHESIS

#182
20220162249
2022-05-26

HIGH-PURITY STEVIOL GLYCOSIDES

#183
20220160805
2022-05-26

seed extract composition and its application in antibiotic-resistant infections

#184
20220160657
2022-05-26

ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS

#185
20220152070
2022-05-19

PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE

#186
20220143059
2022-05-12

COMPOSITIONS AND THERAPEUTIC METHODS

#187
20220135609
2022-05-05

Mannose derivatives for treating bacterial infections

#188
20220125742
2022-04-28

Method of treating major depressive disorder

#189
20220117987
2022-04-21

Methods and compositions relating to the treatment of fibrosis

#190
20220117986
2022-04-21

Antioxidant composition comprising polydatin and acetylcysteine

#191
20220105110
2022-04-07

Composition for the treatment of COVID-19

#192
20220098226
2022-03-31

Methods of preparing steviol glycosides and uses of the same

#193
20220088048
2022-03-24

USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

#194
20220079965
2022-03-17

ACYLATED COMPOUNDS FOR THE TREATMENT OF OCULAR PATHOLOGIES

#195
20220072023
2022-03-10

COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE

#196
20220054459
2022-02-24

Prophylactic and therapeutic drug for nonalcoholic fatty liver disease

#197
20220050057
2022-02-17

Method for maintaining the health of a diabetic patient by preventing the occurrence of diabetic ketoacidosis

#198
20220041639
2022-02-10

Method for separating phenolic acid glucoside compounds from

#199
20220040116
2022-02-10

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

#200
20220023295
2022-01-27

Combination of zibotentan and dapagliflozin for the treatment of endothelin related diseases

#201
20220016216
2022-01-20

SOLID GLP-1 DERIVATIVE COMPOSITIONS FOR ORAL ADMINISTRATION

#202
20220000897
2022-01-06

METHODS FOR TREATMENT OF POST-SURGERY LAXITY OF TENDONS AND TENDON REPAIR

#203
20220000896
2022-01-06

METHODS OF TREATMENT ASSOCIATED WITH ENDOVASULAR GRAFTS

#204
20210401864
2021-12-30

Topical analgesic

#205
20210386770
2021-12-16

Therapeutic agents and methods of producing same

#206
20210379094
2021-12-09

METHOD FOR REDUCING DRUG-INDUCED NEPHROTOXICITY

#207
20210346499
2021-11-11

Nanoparticle delivery system for targeted anti-obesity treatment

#208
20210346418
2021-11-11

Pharmaceutical composition, methods for treating and uses thereof

#209
20210346414
2021-11-11

APPLICATION OF GLYCOSIDES IN THE PREPARATION OF DRUGS FOR PREVENTING AND TREATING DIABETES COMPLICATIONS

#210
20210323990
2021-10-21

Highly potent multimeric e-selectin antagonists

#211
20210308163
2021-10-07

Compositions comprising resveratrolosides and curcumins

#212
20210308162
2021-10-07

NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS

#213
20210308160
2021-10-07

N-palmitoyl-D-glucosamine in a micronized form

#214
20210299153
2021-09-30

Pharmaceutical composition, methods for treating and uses thereof

#215
20210290647
2021-09-23

Compositions for oral cancer or an oropharyngeal cancer

#216
20210283158
2021-09-16

COMPOSITIONS BASED ON ACTIVE PRINCIPLES OF PLANT ORIGIN HAVING EYE PROTECTION ACTION

#217
20210283156
2021-09-16

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#218
20210283100
2021-09-16

ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER

#219
20210268010
2021-09-02

PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE

#220
20210260091
2021-08-26

USE OF SALIDROSIDE AND DERIVATIVE THEREOF IN PREPARATION OF INHIBITOR MEDICAMENT FOR DISEASES OF OPHTHALMIC FIBROSIS CAUSED BY ABNORMALITIES OF EXTRACELLULAR MATRIX PROTEINS

#221
20210260090
2021-08-26

Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines

#222
20210260056
2021-08-26

LOW-DOSE TRIPLE COMBINATION FORMULATION

#223
20210228505
2021-07-29

Method of treating major depressive disorder

#224
20210228501
2021-07-29

Formulation and process for modulating wound healing

#225
20210220379
2021-07-22

PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS

#226
20210220334
2021-07-22

Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof

#227
20210214343
2021-07-15

Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof

#228
20210212991
2021-07-15

Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof

#229
20210212968
2021-07-15

COMBINATIONS COMPRISING AN SSAO/VAP-1 INHIBITOR AND A SGLT2 INHIBITOR, USES THEREOF

#230
20210205399
2021-07-08

Pharmaceutical Composition for Promoting Neurogenesis and Method of Utilizing Gastrodia Elata Extract or Adenosine Analog for Promoting Neurogenesis

#231
20210205324
2021-07-08

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

#232
20210196737
2021-07-01

USE OF TREZASTILBENOSIDE IN MANUFACTURE OF PRODUCT FOR TREATING AND/OR PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE

#233
20210196736
2021-07-01

Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system

#234
20210196683
2021-07-01

Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof

#235
20210196682
2021-07-01

Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof

#236
20210177878
2021-06-17

Methods of mobilizing marrow infiltrating lymphocytes and uses thereof

#237
20210171563
2021-06-10

Compounds and methods for treating bacterial infections

#238
20210161930
2021-06-03

Use of SGLT-2 inhibitors in the drying-off of non-human mammals

#239
20210161929
2021-06-03

USES OF VERBASCOSIDE IN TREATMENT OF DIABETIC-ASSOCIATED KDINEY INJURY AND DIABETIC-ASSOCIATED LIVER INJURY

#240
20210128596
2021-05-06

COMPOSITIONS AND METHODS FOR TREATING SEPTIC CARDIOMYOPATHY

#241
20210128595
2021-05-06

Methods and compositions relating to the treatment of fibrosis

#242
20210128594
2021-05-06

Compositions and methods for treatment of inflammatory disorders

#243
20210122776
2021-04-29

COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS

#244
20210121391
2021-04-29

COMPOSITION COMPRISING VEGETABLE EXTRACTS WITH FLAVONOIDS FOR ALLEVIATING THE MANY EFFECTS OF AIR POLLUTION ON THE SKIN

#245
20210113596
2021-04-22

Glycan therapeutics and method of treating conditions associated with TMAO

#246
20210085739
2021-03-25

ANTIPLATELET ACTIVITY OF THE ACANTHUS MOLLIS SEEDS' TOTAL EXTRACT AND ITS CONSTITUENTS

#247
20210085703
2021-03-25

Compositions and Methods for Preventing or Treating Nephrolithiasis

#248
20210069272
2021-03-11

Methods for skin whitening, ultraviolet radiation protection and suppression of glycation using green mango extracts and compounds obtained therefrom

#249
20210069222
2021-03-11

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#250
20210060046
2021-03-04

Use of verbascoside in preparation of drug for preventing or treating glomerular podocyte injured renal disease

#251
20210052683
2021-02-25

Combination of Rhodiola and Astragalus for the treatment of neurodegenerative diseases

#252
20210052666
2021-02-25

Systems and methods for thrombosis prevention

#253
20210040133
2021-02-11

FOOD OR FEED COMPOSITION FOR IMPROVING COGNITIVE FUNCTION OR MEMORY COMPRISING EXTRACT OF DESALTED SALICORNIA EUROPAEA

#254
20210038627
2021-02-11

USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS

#255
20210038626
2021-02-11

COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2

#256
20210017215
2021-01-21

E-selectin antagonist compounds, compositions, and methods of use

#257
20210015836
2021-01-21

Topical analgesic

#258
20210008011
2021-01-14

METHODS FOR TREATING INFLAMMATORY DISEASES

#259
20210000852
2021-01-07

POLYDATIN PACLITAXEL COMPOSITION, AND APPLICATION IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING GASTRIC CANCER

#260
20200390758
2020-12-17

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

#261
20200376046
2020-12-03

PROBIOTIC RECOLONISATION THERAPY

#262
20200360412
2020-11-19

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#263
20200360408
2020-11-19

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

#264
20200353034
2020-11-12

Pharmaceutical composition for preventing or treating diabetes, containing zinc salt, cyclo-hispro and antidiabetic drug as active ingredients

#265
20200352969
2020-11-12

Nutraceutical composition for the activation of sirtuins with anti-aging/reverse-aging effect

#266
20200352968
2020-11-12

METHODS FOR REDUCING THE WEIGHT LOSS OR INCREASING THE WEIGHT OF A FELINE IN NEED THEREOF

#267
20200338104
2020-10-29

Use of chlorogenic acid in preparation of drug for treating chordoma

#268
20200331947
2020-10-22

Methods of preparing steviol glycosides and uses of the same

#269
20200323832
2020-10-15

Method of Treating Focal Segmental Glomerulosclerosis

#270
20200316150
2020-10-08

Gastroretentive sustained release formulations of

#271
20200315998
2020-10-08

COMPOSITION FOR IMPROVING INTESTINAL BARRIER FUNCTION

#272
20200306246
2020-10-01

Low-dose triple combination formulation

#273
20200297749
2020-09-24

Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages

#274
20200297746
2020-09-24

COMPOSITION FOR REDUCING WEIGHT AND LOWERING LIPID, PREPARATION METHOD THEREFOR AND USE THEREOF

#275
20200270293
2020-08-27

2,7-dibromospiro[fluorene-9,4′-piperidine] compounds

#276
20200268780
2020-08-27

MIXTURE OF INOSITOL DERIVATIVES

#277
20200262858
2020-08-20

Derivatives of amphotericin B

#278
20200253998
2020-08-13

Compositions And Methods For Immunotherapy

#279
20200246365
2020-08-06

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE

#280
20200237794
2020-07-30

TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS

#281
20200222474
2020-07-16

COMPOSITIONS AND METHODS FOR INCREASING PHYTOCHEMICAL BIOAVAILABLITY AND BIOACTIVITY

#282
20200222423
2020-07-16

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT

#283
20200206292
2020-07-02

Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof

#284
20200197429
2020-06-25

Dietary supplement for glycemia control and diabetes prevention

#285
20200197352
2020-06-25

Treatment of metabolic disorders in feline animals

#286
20200197342
2020-06-25

Method for producing a polyphenolic composition from barley malt

#287
20200197325
2020-06-25

METHODS INVOLVING DOWNREGULATING APOBEC3B

#288
20200179328
2020-06-11

Treatment of metabolic disorders in canine animals

#289
20200163886
2020-05-28

Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients

#290
20200157134
2020-05-21

E-selectin antagonist compounds, compositions, and methods of use

#291
20200147179
2020-05-14

Solid glp-1 derivative compositions for oral administration

#292
20200147149
2020-05-14

COMPOSITIONS AND METHODS FOR THE MODULATION OF GUT SENSORY CELLS

#293
20200147130
2020-05-14

Food supplements for use in the prophylaxis and treatment of migraine

#294
20200147005
2020-05-14

Method of treating major depressive disorder

#295
20200121706
2020-04-23

METHOD FOR INHIBITING MYOPIA AND APPLICATION IN PREPARING DRUG

#296
20200113921
2020-04-16

Functionalized saccharides as anti-inflammatory agents

#297
20200113873
2020-04-16

MEDICAMENT

#298
20200101096
2020-04-02

Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease

#299
20200093851
2020-03-26

Glycan therapeutics and related methods thereof

#300
20200093845
2020-03-26

Glycan therapeutics and related methods thereof